A growing international presence through development and by setting up subsidiaries, particularly in Europe.
The Group Executive Committee is chaired by Denis Delval, Chairman and CEO of LFB S.A.
LFB BIOMEDICAMENTS, a wholly-owned subsidiary of LFB SA, specialises in plasma-derived medicinal products. It is headed by Denis Delval.
LFB BIOTECHNOLOGIES, a wholly-owned subsidiary of LFB SA, has its head office in Les Ulis (France) and is a strategic subsidiary of the LFB Group.